Benoit Bachand
11Patents
6h-index
38Co-inventors
66Inventor score
Filing activity: Jun 23, 1997 → Apr 24, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6340690B1 | Antiviral methods using [1,8]naphthyridine derivatives | Human Necessities | 42 | Expired |
| US6605614B2 | [1,8] naphthyridine derivatives having antiviral activity | Human Necessities | 26 | Expired |
| US8748656B2 | Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid | Emerging Cross-Sectional Technologies | 12 | Active |
| US9499480B2 | Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid | Emerging Cross-Sectional Technologies | 9 | Active |
| US8044100B2 | Methods and compositions for treating amyloid-related diseases | Chemistry; Metallurgy | 7 | Active |
| US8835654B2 | Method and compositions for treating amyloid-related diseases | Chemistry; Metallurgy | 7 | Active |
| US10238611B2 | Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid | Emerging Cross-Sectional Technologies | 6 | Active |
| US10857109B2 | Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid | Emerging Cross-Sectional Technologies | 3 | Active |
| US6057314A | Low molecular weight bicyclic thrombin inhibitors | Chemistry; Metallurgy | 2 | Expired |
| US11020360B2 | Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid | Emerging Cross-Sectional Technologies | 1 | Active |
| US9328138B2 | HCV NS3 protease inhibitors | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.